Laura Jones
Psychiatry · Skokie, ILNPI 1457475386
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 27.8% of the total. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 266 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$378
- Corium, LLC$285
- Lundbeck LLC$269
- Neurocrine Biosciences, Inc.$199
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,963100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 94 | $1,382 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $1,002 |
| Otsuka America Pharmaceutical, Inc. | 17 | $378 |
| Corium, LLC | 15 | $285 |
| Lundbeck LLC | 14 | $269 |
| Neurocrine Biosciences, Inc. | 8 | $199 |
| Axsome Therapeutics, Inc. | 9 | $193 |
| Bausch Health US, LLC | 10 | $184 |
| Ironshore Pharmaceuticals Inc. | 7 | $136 |
| Biogen | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $90 |
| Almatica Pharma LLC | 4 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Johnson & Johnson | 3 | $68 |
| Alkermes, Inc. | 2 | $65 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| USWM, LLC | 2 | $44 |
| Tris Pharma Inc | 2 | $43 |
| Neos Therapeutics, LP | 2 | $41 |
| Avanir Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk | 2 | $29 |
| Alfasigma USA, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Indivior Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$4,963 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FetzimaLevomilnacipran Hcl | 13 | $6,728 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 18 | $826 |
| Clonazepam | 70 | $669 |
| Trazodone Hcl | 33 | $628 |
| Bupropion XlBupropion Hcl | 31 | $610 |
| Tranylcypromine Sulfate | 11 | $586 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 23 | $569 |
| Escitalopram Oxalate | 35 | $511 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $454 |
| Aripiprazole | 33 | $392 |
| Lorazepam | 55 | $387 |
| Alprazolam | 36 | $258 |
| Buspirone Hcl | 19 | $196 |
| Mirtazapine | 22 | $194 |
| Zolpidem Tartrate | 32 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieFetzima | $1,382 | $6,72813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Skokie
- Mark ShukhmanSkokie$250K
- John ZajeckaSkokie$76K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Abid NazeerOak Brook$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.